drugset / Trial / NCT02228785
A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer
RandomizedOpen-labelTreatment
Summary
This study was designed to investigate the safety and tolerance of three doses (100µg, 200µg, 500µg) of G17DT for the treatment of patients with colorectal cancer.
Timeline
- Start
- 1994-05
- Primary completion
- 1994-10
- Completion
- —
Outcome
Outcome not reported
Stopped: “Poor local tolerance to injection.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | G17DT Immunogen | Vaccine | 100 ug | Intramuscular |
| Subject | G17DT Immunogen | Vaccine | 200 ug | Intramuscular |
| Subject | G17DT Immunogen | Vaccine | 500 ug | Intramuscular |